Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Platycodon fluid extract is an oral herbal liquid extract derived from the dried roots of *Platycodon grandiflorus* (commonly known as balloon flower or Jie Geng). It is approved in China as a traditional Chinese medicine (TCM) liquid extract for the treatment of cough and excess phlegm. The extract contains active triterpenoid saponins, primarily platycodins (such as platycodin D and D3), which exert expectorant and antitussive activities. These saponins stimulate the secretion of respiratory tract mucus, diluting sputum and facilitating its removal, while also reducing airway inflammation. Shaanxi Fujie Pharmaceutical is a key developer and manufacturer of this approved formulation (under the Chinese approval number 国药准字Z20064030).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on platycodon fluid extract.